- Home
- PEPG vs RPTX Comparison
PEPG vs RPTX Comparison
Compare PEPG & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- RPTX
- Stock Information
- Founded
- PEPG 2018
- RPTX 2016
- Country
- PEPG United States
- RPTX Canada
- Employees
- PEPG N/A
- RPTX N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- PEPG Health Care
- RPTX Health Care
- Exchange
- PEPG Nasdaq
- RPTX Nasdaq
- Market Cap
- PEPG 52.4M
- RPTX 58.8M
- IPO Year
- PEPG 2022
- RPTX 2020
- Fundamental
- Price
- PEPG $1.42
- RPTX $1.49
- Analyst Decision
- PEPG Buy
- RPTX Strong Buy
- Analyst Count
- PEPG 3
- RPTX 3
- Target Price
- PEPG $7.67
- RPTX $4.50
- AVG Volume (30 Days)
- PEPG 216.6K
- RPTX 151.5K
- Earning Date
- PEPG 05-08-2025
- RPTX 05-13-2025
- Dividend Yield
- PEPG N/A
- RPTX N/A
- EPS Growth
- PEPG N/A
- RPTX N/A
- EPS
- PEPG N/A
- RPTX N/A
- Revenue
- PEPG N/A
- RPTX $1,073,000.00
- Revenue This Year
- PEPG N/A
- RPTX N/A
- Revenue Next Year
- PEPG N/A
- RPTX N/A
- P/E Ratio
- PEPG N/A
- RPTX N/A
- Revenue Growth
- PEPG N/A
- RPTX N/A
- 52 Week Low
- PEPG $0.88
- RPTX $0.89
- 52 Week High
- PEPG $19.30
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- PEPG 46.62
- RPTX 66.91
- Support Level
- PEPG $1.35
- RPTX $1.33
- Resistance Level
- PEPG $1.55
- RPTX $1.41
- Average True Range (ATR)
- PEPG 0.15
- RPTX 0.05
- MACD
- PEPG -0.00
- RPTX 0.01
- Stochastic Oscillator
- PEPG 18.42
- RPTX 100.00
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.